| NOF in the News, Osteoporosis in the News

One our Corporate Advisory Roundtable members, Juvent, announced very positive results from the St. Jude Children’s Hospital Clinical Trial. An 11% increase in bone density was seen in childhood cancer survivors through their product, Juvent® Dynamic Motion Therapy Platform. The study was published in the Journal of the American Medical Association (JAMA) Oncology. To learn more, click here.